Two different KIT mutations may lead to different responses to imatinib in metastatic gastrointestinal stromal tumor

키워드

참고문헌 (5)

1. Miettinen M, "Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis", Arch Pathol Lab Med, 130, pp.1466~1478 (2006)
2. Heinrich MC, "Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor", J Clin Oncol, 21, pp.4342~4349 (2003)[DOI]
3. Andersson J, "The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors", Am J Pathol, 160, pp.15~22 (2002)[DOI]
4. Corless CL, "KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors", J Mol Diagn, 6, pp.366~370 (2004)[DOI]
5. Dufresne A, "Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology", BMC Cancer, 14, pp.632~ (2014)[DOI]

관련 논문AI추천